Novo Nordisk A S
NONOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.
Other share classesNVO
Q3 2024 vs. Q2 2024
How the institutions holding Novo Nordisk A S changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 3 | 2 | −1 |
| Shares | 170.1K | 5.48K | −164.6K (−96.8%) |
| Value | $24.5M | $643.4K | −$23.9M (−97.4%) |
New holders (0)
Institutions that held Novo Nordisk A S at the end of Q3 2024 but not at the end of Q2 2024.
None.
Sold out (1)
Institutions that held Novo Nordisk A S at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Kennedy Capital Management, Inc. | 164,577 | $23.7M |